David Krempa serves as Executive at Eton Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, David Krempa has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 12, 2025 involved selling 6,264 shares valued at $106.5K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 12, 2025 | ETON | $106.5K | Payment | 6,264 | $17.00 | Discretionary |
David Krempa currently holds 632,180 shares of Eton Pharmaceuticals, Inc. (ETON), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Krempa has been a net neutral trader of ETON stock. They have purchased $0 and sold $0 worth of shares.
David Krempa's most recent insider trade was on Dec 12, 2025, when they sold 6,264 shares at $17.00 per share.
Get notified when new Form 4 filings are submitted